Oncoblast vs FHNO2025
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Oncoblast
This educational game allows hematology and oncology providers to earn continuing education credits. It offers an interactive learning experience with real-time feedback, designed to enhance medical knowledge in a fun and engaging way.
- Earn continuing education credits
- Educational games for medical professionals
- Interactive learning experience
- Real-time feedback
- Focus on hematology and oncology
Read full descriptionHide full description
The OncoBlast™ app, created by the Binaytara, offers a unique gaming experience for hematology and oncology providers. This app allows medical professionals in hematology and oncology to engage in educational games, enabling them to earn continuing education credits while playing. OncoBlast™ is available at no cost and provides interactive, real-time feedback to enhance learning experiences for providers. Binaytara is a non-profit organization dedicated to improving healthcare outcomes through advocacy, education, and innovation. Founded with a vision to create a significant impact in the healthcare sector, Binaytara focuses on addressing gaps in medical knowledge and practice, especially in the fields of hematology and oncology. Their commitment to education and training extends beyond traditional methods, embracing technology and interactive platforms to reach a broader audience of healthcare professionals. This app, OncoBlast™, takes us one step closer towards this commitment.
FHNO2025
Read full descriptionHide full description
Mobile app for FHNO2025 where delegates can see the various programs happening in the conference, they can bookmark interested programs, show interest to speakers and get alerts before the program starts or intimate if there any change in the timings.
Screenshots
Verdict
The clearest difference is update cadence: FHNO2025 at every 4 days against Oncoblast's every 6 weeks. FHNO2025 also leads on iOS requirement (13.0 vs 15.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Oncoblast ships an update every 6 weeks, FHNO2025 every 4 days. The most recent releases landed on November 3, 2026 and October 30, 2026 respectively.
| Parameter | Oncoblast | FHNO2025 |
|---|---|---|
| Price | Free | Free |
| Rating | 3.8 (6 ratings) — better | — |
| Positive reviews | 0.0% of reviews | — |
| Number of ratings | 6 — better | — |
| Update frequency | Every 6 weeks | Every 4 days — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod — better | iPhone, iPod |
| Requires iOS | 15.0 | 13.0 — better |
| Further details — not scored | ||
| Size | 92 MB | 103 MB |
| Age rating | 17+ | 4+ |
| Developer | BINAYTARA FOUNDATION | Kokonet Solutions Pvt Ltd |
In-app purchases
Oncoblast
No in-app purchases
FHNO2025
No in-app purchases
